From September 8 to 11, 2016, the 21st National Ophthalmology Academic Conference of the Chinese Medical Association was held at the Suzhou International Expo Center. Professional manufacturers of ophthalmic pharmaceuticals and ophthalmic devices from 17 countries around the world participated in the conference and engaged in academic exchanges. Huiren Landtech exhibited at the show, debuting its newly developed, independently researched products for the first time and receiving considerable attention. During the exhibition, more than 600 ophthalmologists and 400 distributors visited the booth to learn about the company and its products. Among the exhibitors were well-known domestic and international companies in the ophthalmology field, including Novartis, Abbott, Alcon, Bausch + Lomb, Santen, and Shenyang Xingqi.

In August 2016, Huonland completed the on-site inspection for GMP certification of its ophthalmic formulation production line. The company has introduced a globally leading integrated “blow-fill-seal” automated production line that complies with international GMP standards and has established an efficient quality management system. The products exhibited at this event include brimonidine tartrate for open-angle glaucoma, sodium hyaluronate artificial tears free of preservatives, and surgical irrigation solutions. These products have attracted physicians and distributor representatives with their unique advantages. In particular, the surgical irrigation solutions—following the country’s increasingly stringent drug regulatory measures in the second half of 2015, which reclassified irrigation solutions from medical devices to pharmaceuticals—have led to the cessation of production by domestic manufacturers previously engaged in this sector, resulting in a supply shortage in the market. This situation has created an excellent opportunity for our company’s products to enter the market.

Huonland will fully leverage the information gathered at this exhibition to develop a sales strategy and establish a marketing team within the year, and will aggressively expand into the market next year.